Edition:
United Kingdom

Cellular Biomedicine Group Inc (CBMG.OQ)

CBMG.OQ on NASDAQ Stock Exchange Global Market

10.55USD
15 Dec 2017
Change (% chg)

$0.05 (+0.48%)
Prev Close
$10.50
Open
$10.35
Day's High
$10.65
Day's Low
$10.35
Volume
2,980
Avg. Vol
7,051
52-wk High
$13.75
52-wk Low
$5.15

Chart for

About

Cellular Biomedicine Group, Inc. (CBMG) is a biomedicine company. The Company is engaged in the development of treatments for cancerous and degenerative diseases utilizing cell-based technologies. The Company operates in Biomedicine Cell Therapy segment. The Company's technology includes platforms, such as Immune Cell therapy... (more)

Overall

Beta: 2.74
Market Cap(Mil.): $147.44
Shares Outstanding(Mil.): 14.11
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Cellular Biomedicine Group reports qtrly ‍loss per share $0.43

* Cellular Biomedicine Group reports third quarter financial results and recent operational highlights

09 Nov 2017

BRIEF-Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes

* Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes

06 Nov 2017

BRIEF-BioLife Solutions CryoStor cell freeze media embedded in Cellular Biomedicine Group clinical trial of AlloJoin

* BioLife Solutions CryoStor cell freeze media embedded in Cellular Biomedicine Group clinical trial of AlloJoin Source text for Eikon: Further company coverage:

19 Sep 2017

BRIEF-Cellular Biomedicine Q2 ‍loss per share $0.43​

* Cellular Biomedicine Group reports second quarter and first half 2017 financial results and business highlights

08 Aug 2017

Earnings vs. Estimates